Application of nafamostat mesilate in preparing drugs for preventing and curing ischemic cerebral apoplexy
Patent Information
- Authority / Receiving Office
- CN ยท China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- JIANGSU DURUI PHARMACEUTICAL CO LTD
- Publication Date
- 2013-01-16
- Estimated Expiration
- Not applicable ยท inactive patent
Smart Images
Figure 1 Figure 2 Figure 3
Abstract
Description
Technical field:
[0001] The invention relates to the technical field of medicine, in particular to the new application of nafamostat mesylate for preventing and treating ischemic cerebral apoplexy. Background technique:
[0002] According to statistics in recent years, there are about 1.3 to 1.5 million new cases of cerebral apoplexy in my country every year, and about 1 million deaths, which is 4 to 5 times higher than that in European and American countries. At present, the incidence of stroke in my country is increasing at an annual rate of nearly 9%. Stroke has the characteristics of high morbidity, high mortality and high disability rate, which brings a heavy burden to individuals, families and society. Ischemic stroke accounts for 70% of the total number of stroke patients. It refers to the disorder of cerebral blood flow and ischemic necrosis of brain tissue caused by various reasons, resulting in corresponding neurological deficit symptoms. Clinically common stroke...